Morgan Stanley Upgrades Amicus Therapeutics (FOLD) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/3/2026

1. NKE
2. USO
3. SPY
4. ACN
5. NVDA
6. FICO
7. TRU
8. TLT
9. LAES
10. WBD

December 19, 2023 3:12 AM EST
Get Alerts FOLD Hot Sheet
Price: $14.49 --0%

Rating Summary:
    12 Buy, 9 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE

Morgan Stanley analyst Jeffrey Hung upgraded Amicus Therapeutics (NASDAQ: FOLD) from Equalweight to Overweight with a price target of $20.00 (from $15.00).


For an analyst ratings summary and ratings history on Amicus Therapeutics click here. For more ratings news on Amicus Therapeutics click here.


Shares of Amicus Therapeutics closed at $12.66 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Upgrades